Vahe Bedian

Viridian Therapeutics

“FairJourney Biologics generated a comprehensive data package for a Viridian project, whereby they expressed, purified and characterized 17 lead antibody constructs. The characterization included biophysical properties, accelerated stability, solubility assessment, self-association potential, affinity determination and epitope binning. In addition, cell-based assays were developed to assess the functional potency of the lead molecules. The production and characterization were conducted in record time and enabled prioritization of top leads to progress towards manufacturing cell line generation. The FairJourney team was very responsive to our needs, provided helpful technical advice where needed, and was a pleasure to work with.”

vahe-bedian

Paragon Therapeutics

FairJourney Biologics has been a valuable CRO to Paragon Therapeutics since foundation. In addition to their renowned expertise in discovery and engineering of antibodies, their production and biophysical characterization services enable a smooth progress and completion of programs. The FJB team has generated comprehensive and high-quality data packages, has proven to be flexible and consistently delivers results on time, greatly supporting Paragon's research pipeline.

paragon-therapeuticspy

Takayuki Tatamiya

Director. Daiichi Sankyo Co., Ltd.

We had the pleasure of working with FairJourney Biologics to obtain highly selective antibodies, a task that was anticipated to be particularly challenging. Remarkably, they succeeded in obtaining these antibodies within a short timeframe and have completed three independent difficult targets with exceptional outcomes. Their team, comprised of highly skilled technicians, provided invaluable guidance and optimization throughout each project. The workflow was seamless, with comprehensive data provided at every stage. We unequivocally regard FairJourney Biologics as the premier partner for acquiring antibodies for complex applications.

takayuki-tatamiya

Arnout Gerritsen

Associate Director, Assay and Bioanalytical Science at Genmab

“The experienced team of FairJourney Biologics worked with us in a very pleasant and collaborative way to develop several assay tools. They demonstrated to be very flexible and delivered on time.”

arnout-gerritsen

Dr. Jesús Salvador

Assistant Professor, National Center for Biotechnology, CNB-CSIC

“I strongly recommend FairJourney Biologics for the Service of sequencing mAb variable domains. They have performed an outstanding work solving all the technical problems in a reasonable period of time. Moreover, they have provided a great quality-price ratio.”

dr.-jesús-salvador

Hans de Haard

CSO, argenx

“FairJourney Biologics has demonstrated the capacity to deliver high quality antibody engineering services. The team is very experienced in phage display for the discovery of antibodies from rodent immune repertoires for diagnostic and therapeutic applications. Humanization is performed by affinity driven selections of libraries to avoid loss in potency. Desired specificity and optimal affinities can be achieved by applying appropriate selection methods thereby delivering leads useful for the development of highly specific and sensitive diagnostic assays. The outstanding track record of its research team, has enable the company to provide us with new antibodies with excellent characteristics.”

hans-de-haard

Mark Vaeck

CEO, Complix

“FairJourney Biologics has shown excellent performance in a challenging project. Their team has demonstrated to be focused on guarantying high-quality results in a competitive timeframe and at an affordable cost.”

mark-vaeck

Steve Holmes

COO, Capella Bioscience

“Capella Bioscience is happy with the partnership with FairJourney Biologics for being capital efficient. Such a big antibody discovery team gives us the peace of mind, knowing that they have enough expertize to work with us.”

steve-holmes

John Wijdenes

Mabdesign and CEOand consultant, AD&T consultancy

“I had the opportunity to work with FairJourney Biologics since last year and I am impressed by the skills and speed the different projects are delivered. I was personally involved in a project in summer 2013 in which we pulled out together 121 leads of highly specific antibodies in just 3 days. Moreover, the whole teams respires such a enthusiasm that it is a pleasure to work with FairJourney Biologics and I can recommend them to anyone looking for desired new antibodies.”

john-wijdenes

Mark Throsby

CSO, Merus

FairJourney Biologics was founded by a group of scientists that have a significant track record in generating therapeutic antibodies to industry standards. They have consistently impressed us with their speed and expertise.

mark-throsby

Developable leads. Not just hits

FairJourney Bio integrates synergistic discovery platforms and structural insight to strengthen early-stage antibody decisions. By coordinating parallel technologies from antigen strategy through characterization, we enable confident progression toward development.

FairJourney Bio integrates synergistic discovery platforms and structural insight to strengthen early-stage antibody decisions. By coordinating parallel technologies from antigen strategy through characterization, we enable confident progression toward development.

FairJourney Bio integrates synergistic discovery platforms and structural insight to strengthen early-stage antibody decisions. By coordinating parallel technologies from antigen strategy through characterization, we enable confident progression toward development.

Engineering the Highest Probability of Success

FairJourney integrates best-in-class antibody repertoires, parallel discovery platforms, and predictive optimization within a unified workflow. By embedding high-resolution structural insights early in the discovery phase, we enable data-driven candidate selection and de-risk downstream development.

Engineering the Highest Probability of Success

FairJourney integrates best-in-class antibody repertoires, parallel discovery platforms, and predictive optimization within a unified workflow. By embedding high-resolution structural insights early in the discovery phase, we enable data-driven candidate selection and de-risk downstream development.

Engineering the Highest Probability of Success

FairJourney integrates best-in-class antibody repertoires, parallel discovery platforms, and predictive optimization within a unified workflow. By embedding high-resolution structural insights early in the discovery phase, we enable data-driven candidate selection and de-risk downstream development.

Proprietary Discovery & Engineering Platforms

Enabling Parallel Decision-Making

Proprietary

Mammalian Display®

Identifying the right Antibody first time

Cryo-EM

Solving every question with deep structural insights

Tumbler™

The Tumbler advantage: Speed, Stability & ROI

B-Cell

Dual engine, oneplatform: Entire immune response

Tailored Solutions Across the Antibody Journey

Engage Where Your Data Requires

Antibody journey

Tailored Solutions Across the Antibody Journey

Engage Where Your Data Requires

Antibody journey

Tailored Solutions Across the Antibody Journey

Antibody journey

Long-Term Scientific Partnerships

250+

industry projects

1,400+

projects completed

19

partner assets in clinical trials or on market 

14

years corporate experience

Trusted by Leading Biotech and Pharma Partners

AMGEN

AMGEN

AMGEN
Astrazeneca

Astrazeneca

Astrazeneca
Bayer

Bayer

Bayer
Bristol Myers Squibb

Bristol Myers Squibb

Bristol Myers Squibb
Genentech

Genentech

Genentech
Johnson & Johnson

Johnson & Johnson

Johnson & Johnson
Lilly

Lilly

Lilly
MSD

MSD

MSD
Takeda

Takeda

Takeda
Regeneron

Regeneron

Regeneron

Trusted by Leading Biotech and Pharma Partners

AMGEN

AMGEN

AMGEN
Astrazeneca

Astrazeneca

Astrazeneca
Bayer

Bayer

Bayer
Bristol Myers Squibb

Bristol Myers Squibb

Bristol Myers Squibb
Genentech

Genentech

Genentech
Johnson & Johnson

Johnson & Johnson

Johnson & Johnson
Lilly

Lilly

Lilly
MSD

MSD

MSD
Takeda

Takeda

Takeda
Regeneron

Regeneron

Regeneron

Trusted by Leading Biotech and Pharma Partners

AMGEN

AMGEN

AMGEN
Astrazeneca

Astrazeneca

Astrazeneca
Bayer

Bayer

Bayer
Bristol Myers Squibb

Bristol Myers Squibb

Bristol Myers Squibb
Genentech

Genentech

Genentech
Johnson & Johnson

Johnson & Johnson

Johnson & Johnson
Lilly

Lilly

Lilly
MSD

MSD

MSD
Takeda

Takeda

Takeda
Regeneron

Regeneron

Regeneron

What Our Partners Say

Recent Milestones

Fullspectrum Characterization

fullspectrum-characterization

AnyFormat Manufacturing

anyformat-manufacturing

DeepDesign Engineering

deepdesign-engineering

FunctionInsight Assays

functioninsight-assays

B-Cell Navigator

b-cell-navigator

Solutions

solutions

Platforms & Technologies

platforms-technologies

Why FJBio

why-fjbio

Events & Resources

events-resources

Company

company

About

about

Antibody Discovery

antibody-discovery

Protein Production

protein-production

AtomicLevel Cryo-EM

atomic-level-cryo-em

Biologistics

biologistics

Leadership

leadership

Careers

careers

News & Insights

news-insights

Case Studies

case-studies

Fact Sheets

fact-sheets

CellCraft Solutions

cellcraft-solutions

Cryo-EM

cryo-em

Display Platforms

display-platforms

Events

events

Library Diversity

library-diversity

MultiPath Discovery

multipath-discovery

Publications & Posters

publications-posters

Resources

resources

Screening | Analytics | Data Engines

screening-analytics-data-engines

Single B-Cell Screening

single-b-cell-screening

The Antibody Series Conference

the-antibody-series-conference

Tumbler™

tumbler

Webinars

webinars

White papers

whitepapers

Contact Us

contact-us